Paul Lountzis
Lountzis Asset Management
Paul Lountzis UnitedHealth Group Incorporated stake
total: 139
Lountzis Asset Management UNH trades
- Total transactions:
- 21
- New positions:
- 1
- Added:
- 3
- Reduced:
- 17
- Held since:
- 2020 Q2
- Held for:
- 25 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Paul Lountzis holds 10,122 UnitedHealth Group Incorporated (UNH) shares with a market value of roughly $4.21M accounting for 1.33% of the overall portfolio. To date, the estimated cost basis is nearly $306.12 for "buy" trades and estimated average "sell" price is $462.6. Lountzis Asset Management first purchased UNH in 2020 Q2, initially acquiring 12,581 shares. Since the initial investment in UnitedHealth Group Incorporated (UNH), Lountzis Asset Management has made 20 more transactions.
When did Paul Lountzis buy UnitedHealth Group Incorporated (UNH)?
Paul Lountzis first invested in UnitedHealth Group Incorporated (UNH) in 2020 Q2 at the reported quarter-end price of $294.97 per share.
What's the cost basis of Lountzis Asset Management's UNH stake?
The estimated cost basis for UnitedHealth Group Incorporated (UNH) stake is around $306.12 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $306.12
- Weighted AVG sell price:
- $462.60
Paul Lountzis's historical trades in UnitedHealth Group Incorporated
21 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.33%
|
10,122
|
$415.63
|
$4,207,007
|
-5.24% (-560)
|
-0.09%
|
|
2026 Q1
|
1.06%
|
10,682
|
$270.59
|
$2,890,442
|
-0.11% (-12)
|
-0%
|
|
2025 Q4
|
1.25%
|
10,694
|
$330.11
|
$3,530,196
|
-1.43% (-155)
|
-0.02%
|
|
2025 Q1
|
1.72%
|
10,849
|
$420.00
|
$4,556,580
|
-1.65% (-182)
|
-0.03%
|
|
2024 Q4
|
2.36%
|
11,031
|
$505.86
|
$5,580,142
|
-3.62% (-414)
|
-0.09%
|
|
2024 Q3
|
2.78%
|
11,445
|
$584.68
|
$6,691,662
|
+0.04% (+5)
|
+0%
|
|
2024 Q2
|
2.72%
|
11,440
|
$509.26
|
$5,825,934
|
-0.48% (-55)
|
-0.01%
|
|
2023 Q4
|
3.30%
|
11,495
|
$526.47
|
$6,051,773
|
-0.68% (-79)
|
-0.02%
|
|
2023 Q2
|
3.26%
|
11,574
|
$510.89
|
$5,913,000
|
-7.23% (-902)
|
-0.27%
|
|
2023 Q1
|
3.49%
|
12,476
|
$472.59
|
$5,896,000
|
+7.03% (+819)
|
+0.23%
|
|
2022 Q4
|
3.33%
|
$475.17
|
+0.13% (+15)
|
|||
|
2022 Q3
|
3.99%
|
$504.98
|
-2.33% (-278)
|
|||
|
2022 Q2
|
4.10%
|
$513.59
|
-1.46% (-177)
|
|||
|
2022 Q1
|
3.42%
|
$509.97
|
-0.09% (-11)
|
|||
|
2021 Q4
|
3.47%
|
$502.14
|
-0.31% (-38)
|
|||
|
2021 Q3
|
2.96%
|
$390.74
|
-0.17% (-21)
|
|||
|
2021 Q2
|
2.97%
|
$400.35
|
-2.17% (-270)
|
|||
|
2021 Q1
|
3.08%
|
$372.04
|
-0.51% (-64)
|
|||
|
2020 Q4
|
3.22%
|
$350.69
|
-0.24% (-30)
|
|||
|
2020 Q3
|
3.36%
|
$311.79
|
-0.40% (-50)
|
|||
|
2020 Q2
|
3.52%
|
$294.97
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.